Бейінді маман / Узкий маман BERRİN BALIK

Гематология

Медипол Ажыбадем аймақтық ауруханасы
Бейінді маман / Узкий маман BERRİN BALIK

Туған жері

DİYARBAKIR

Тілдер

İNGİLİZCE

Тәжірибе

2025

Oxford Translational Myeloma Center (Botnar Research Institude) Oxford Universitiy Churchill Hospital

2024 - 2024

Southampton University Hospital

2022

Gazi Yasargil Eğitim ve Araştırma Hastanesi

2020 - 2022

Medipol Üniversitesi Tıp Fakültesi

2018 - 2020

Mersin üniversitesi Tıp Fakültesi

2017 - 2018

Bismil İlçe Devlet Hastanesi

2013 - 2017

Dicle Üniversitesi Tıp Fakültesi

2012 - 2013

Çınar İlçe Devlet Hastanesi

Білім

2022

İstanbul Medipol Üniversitesi Tıp, İç Hastalıkları Hematoloji

2017

Dicle Üniversitesi Tıp Fakültesi, İç Hastalıkları

2012

İstanbul Üniversitesi, İstanbul Tıp Fakültesi

Жарияланымдар

A01 Balik, B.; Beybolat, D.; Alabdullah, O.; Erkaya, H.; Genc, N.I.; Gerenli, B.; Ertas, E.; Atceken, Z.; Aytulu, T.; Tan, T.; et al. Nutritional Risk, Weight Loss, and Inflammatory Profiles During Autologous Stem Cell Transplantation: Clinical Correlates in Patients with Lymphoma and Multiple Myeloma. Nutrients 2026, 18, 3636. https://doi.org/10.3390/nu18213636

A02 Knight, E., Krishnamoorthi, A., Balik, B. et al. SECURE study: baseline findings from a UK prospective cohort of incidentally detected MGUS. Blood Cancer J. 16, 119 (2026). https://doi.org/10.1038/s41408-026-01576-x

A03 Balık B, Demircan V, Karakuş A, Gökdemir B, Ayyıldız O. Plasmapheresis Activity of a Tertiary Referral Centre Indicating Wide-Spread Interdisciplinary and Safe Use of Therapeutic Plasma Exchange, with an Emphasis on Thrombotic Thrombocytopenic Purpura. Cam and Sakura Med J. 2026 Apr 28. doi: 10.4274/csmedj.galenos.2026.2026-2-2. Epub ahead of print.

A04 Balık B, Mutlu YG, Sevindik ÖG. Does the time since diagnosis affect the quality of life in patients with haematological malignancies at early and late period? J Med Palliat Care. 2025;6(4):396-402.

A05 Agarwal, G., Kazeroun, M., Salazar, M., McBean, K., Kannan, A., Larham, J., Varghese, S., Balik, B., Browning, J., Caulier, A., Chan, Y.L.T., Giles, H., Jenner, M., Kishore, B., Pratt, G., Rabin, N., Robinson, R., Talbot, A., van de Wyngaert, Z., Xu, K., Moore, S., Boyle, E., Ansari-Pour, N., Ramasamy, K., Hamblin, A., Thakurta, A. and Gooding, S. (2025), NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma. Br J Haematol. https://doi.org/10.1111/bjh.70111

A06 Balık B, Akdeniz A, Koyuncu MB, et al. Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center. J Curr Hematol Oncol Res. 2025;3(3):57-61.

A07 Beyler Ö, Baş H, Balık B, et al. Hereditary thrombophilia and recurrent pregnancy loss: is it time to reassess routine genetic testing? J Curr Hematol Oncol Res. 2025;3(2):22-26.

A08 Balık B, Mutlu YG, Sevindik ÖG. Myeloid differentiation primary response 88 expression in central nervous system lymphomas. J Curr Hematol Oncol Res. 2024;2(4):83-86.

A09 Germline CEBPA Mutation as a Rare Cause of Chronic Neutropenia Abdullah Emre Askin, Sebnem Bektas, Istemi Serin, Yasa Gul Mutlu, Berrin Balik Aydin & Omur Gokmen Sevindik Indian J Hematol Blood Transfus (2024). https://doi.org/10.1007/s12288-023-01725-3

A10 Intravaskuläres B-Zell-Lymphom mit generalisierten Teleangiektasien Vedat Bugra Erol, Yaşa Gul Mutlu, Berrin Balik, Ali Mert, Sena Mergen, Mahmut Mergen, Istemi Serin, Aslı Cakir, Ferhat Ozden, Omur Gokmen Sevindik https://doi.org/10.1111/ddg.15148_g

A11 Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics? Serin, Istemi & Sevindik, Omur & Balik Aydin, Berrin & Melek, Elif & Mutlu, Yaşa & BİLGEN, Hülya & Beköz, Hüseyin & Kaynar, Leylagül. (2023). Transfusion and Apheresis Science. 62. 10.1016/j.transci.2023.103809.

A12 Should Core Needle Lymph Node Biopsy be a Relevant Alternative to Surgical Excisional Biopsy in Diagnostic Work Up of Lymphomas? Yaşa Gül Mutlu 1 , Berrin Balık Aydın 1 , Aslı Çakır 2 , Özlem Canöz 3 , Cengiz Erol 4 , Ömür Gökmen Sevindik 1 Eurasian Journal of Medicine 55(2):114-119 June 2023 55(2):114-119 DOI:10.5152/eurasianjmed.2023.0060

A13 Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient Süreyya Yiğit Kaya, Sebnem Bektas, Abdullah Emre Askin, Berrin Balik Aydin, Yaşa Gül Mutlu & Ömür Gökmen Sevindik Ann Hematol 102, 1599–1600 (2023). https://doi.org/10.1007/s00277-023-05231-4

A14 Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis Serkan Guven,1 Boran Yavuz,1 Elcin Erdogan Yucel,1 Aylin Fatma Karatas,1 Guner Hayri Ozsan,1 Fatih Demirkan,1 Bulent Undar,1 Mehmet Ali Ozcan,1 Hatice Demet Kiper,2 Tugba Cetintepe,2 Mesut Gocer,3 Erdal Kurtoglu,3 Berrin Balik Aydin,4 Omur Gokmen Sevindik,4 Sureyya Yigit Kaya,5 Inci Alacacioglu DOI: 10.14744/ejmo.2023.64688 EJMO 2023;7(1):49–56

A15 CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study Ufuk Demirci, Hakkı Onur Kırkızlar, Elif G. Ümit, Vildan Gürsoy, İbrahim Ethem Pınar,Volkan Baş, Berrin Balık Aydın…,Ahmet Muzaffer Demir Journal of Hematopathology volume 15, pages203–213 (2022)

A16 First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS) Omur Gokmen Sevindik1, Yasa Gul Mutlu1, Berrin Balık Aydın1, Istemi Serin2 June 2022 HemaSphere 6(7):e728 DOI: 10.1097/hs9.0000000000000728

A17 Mutation profile of the patients diagnosed with myeloid neoplasia tested with next generation sequencing and clinical implications Yasa Gul Mutlu, Berrin Balik Aydin, Akif Ayaz, Fatma Seca, Omur Gokmen Sevindik January 2022 Annals of Medical Research 29(4):406 DOI: 10.5455/annalsmedres.2021.06.480 LicenseCC BY-NC-ND 4.0

A18 Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation Yaşa Gül Mutlu, Berrin Balik Aydin, Cem Erdogan, Deniz Kizilaslan, Hüseyin Saffet Beköz, Aliihsan Gemici, Leylagül Kaynar & Ömür Gökmen Sevindik October 2022 Indian Journal of Haematology and Blood Transfusion DOI: 10.1007/s12288-022-01575-5

A19 To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission Omur Gokmen Sevindik, Mahmut Mergen, Sena Mergen, Yasa Gul Mutlu, Berrin Balık Aydın & Istemi Serin July 2022Annals of Haematology 101(11) DOI: 10.1007/s00277-022-04938-0

A20 Evaluation of neurological imaging after hematopoietic stem cell transplantation in adults Sevil Sadri1* , Burcu Polat2 , Berrin Balik Aydin1 , Hakan Kocar1 , Aliihsan Gemici1 , Huseyin Saffet Bekoz1 , Omur Gokmen Sevindik1 , Fatma Deniz Sargin1 January 2022Eastern Journal of Medicine 27(3):437-445 DOI: 10.5505/ejm.2022.54765

A21 Clinical Characteristics and Outcome of COVID-19 in Turkish Hematological Malignancy Patients Sinem Civriz Bozdağ1, Güldane Cengiz Seval1, İpek Yönal Hindilerden2, Fehmi Hindilerden3, Neslihan Andıç4, Mustafa Baydar5, Lale Aydın Kaynar6, Selami Koçak Toprak1, Hasan Sami Göksoy7, Berrin Balık Aydın8…, Reyhan Diz Küçükkaya28, Güner Hayri Özsan16 DOI: 10.4274/tjh.galenos.2021.2021.0287 Turk J Hematol 2022;39:43-54

A22 Persistent Polyclonal B-cell Lymphocytosis with Binucleated Lymphocytes (PPBL) Berrin Balık Aydın, Yaşa Gül Mutlu, Ömür Gökmen Sevindik March 2021Turkish Journal of Haematology 38(2)DOI: 10.4274/tjh.galenos.2021.2021.0061

A23 The potential gastrointestinal side effects of excipients in imatinib preparations Aydan Akdeniz1 , Gulhan Orekici2 , Berrin Balik1 , Mahmut Bakir Koyuncu1 , Mehmet Ali Ucar1 , Anil Tombak1 , Nalan Tiftik3 , Eyup Naci Tiftik1 January 2020Annals of Medical Research 27(12):3071 DOI: 10.5455/annalsmedres.2020.03.250

A24 Assessment of the underlying causes of the immune thrombocytopenia: Ten years experience Mehmet Sinan Dal,1 Abdullah Karakus,2 Tuba Dal,3 Berrin Balik Aydin,4 Elif Hattapoglu,5 Mehmet Önder Ekmen,6 Turgay Ulas,7 Orhan Ayyildiz8 J Pak Med Assoc. 2017 Jul;67(7):1004-1008.

A25 Serum uric acid and inflammation in patients with immune thrombocytopenic purpura: preliminary results. Dal MS1, Karakus A, Aydin BB, Ekmen MO, Ulas T, Ayyildiz O. Eur Rev Med Pharmacol Sci. 2015 Nov;19(22):4385-9.

A26 Levothyroxine intoxication: Case report Faruk Kılınç 1 , Berrin Balık Aydın 2 , Zafer Pekkolay 1 , Melike Elif Çelik 2 , Alpaslan Kemal Tuzcu Dicle Medical Journal doi: 10.5798/diclemedj.0921.2015.02.0571